Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

NECN

Auto bailout: The best medicine?
Florida Times-Union, FL - 4 hours ago
By The Times-Union They already received $25 billion in low interest government loans intended to help them transition to a new generation of fuel efficient ...
Detroit bailout? No way! The Oregonian - OregonLive.com
American taxpayers should not be forced to bailout Big Three Statesville Record & Landmark
Don't bail out on accountability for auto industry Pocono Record
CounterPunch
all 469 news articles


University of South Alabama College of Medicine Chooses MDaudit(TM)
MarketWatch - 15 hours ago
... WIRE) -- Hayes Management Consulting announced today that it will provide its MDaudit(TM) software to University of South Alabama College of Medicine. ...


MinuteClinic co-founder launches e-medicine startup
Bizjournals.com, NC - 8 hours ago
Nearly a decade after he came up with the idea that became MinuteClinic, Rick Krieger thinks he’s come across a new way to change health care. ...


Exploring: medicine the world of
Asbury Park Press, NJ - 1 hour ago
The club, which offers education and activities for teenagers considering a career in medicine, is a program of Learning for Life, a Boy Scouts of America ...


TheMedGuru

Three Employees Fired After Patient Chokes on Medicine, Dies
FOXNews - Nov 20, 2008
GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ...
Firings a good first step in neglect case CharlotteObserver.com
all 39 news articles


Product Reviews

Detroit prepares to swallow some bitter medicine
Financial Times, UK - 8 hours ago
By Bernard Simon in Los Angeles Among the many conditions imposed on Chrysler by Washington in the bail-out of 1979, none is said to have angered the ...
Auto bailout must come with strings Visalia Times-Delta
United States needs to help automakers Vineland Daily Journal
all 682 news articles


National Academy of Sports Medicine Launches New Course ...
MarketWatch - 21 hours ago
CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ...


Entry Level Finding Ways to Help Children With Cancer
New York Times, United States - 17 hours ago
She comes to the job with a master’s degree in Oriental medicine from Touro College and a lifelong love of cooking. On doing acupuncture on small children: ...


PR Web (press release)

BodyLogicMD Sponsors American Academy of Anti-Aging Medicine
MarketWatch - Nov 20, 2008
"It is a natural step for BodyLogicMD in terms of demonstrating our growth and support in the field of anti-aging medicine and bioidentical hormone therapy. ...
BodyLogicMD Opens Bioidentical Hormone Therapy Location in Chicago PR Web (press release)
all 12 news articles


The wrong medicine
TheDay, CT - 23 hours ago
If we had any reasonable expectation that a $25 billion federal loan would fix what ails the Detroit auto industry, we would support it. ...

Medicine - Google News

home | site map
© 2006